Search Ontology:
ChEBI
brivaracetam
- Term ID
- CHEBI:133013
- Synonyms
-
- (2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide
- 2-(2-Oxo-4-propylpyrrolidin-1-yl)butanamide
- brivaracetam
- Briviact
- UCB 34714
- UCB34714
- Definition
- A non-proteinogenic amino acid derivative that is butanamide in which the pro-S hydrogen at position 2 is replaced by a (4R)-2-oxo-4-propylpyrrolidin-1-yl. Used for treatment of partial onset seizures related to epilepsy.
- References
-
- cas:357336-20-0
- drugcentral:5068
- kegg.drug:D08879
- pubmed:26515103
- pubmed:26664121
- pubmed:26666500
- pubmed:26719676
- pubmed:26740317
- pubmed:26760311
- pubmed:26891946
- pubmed:26899665
- pubmed:26920914
- pubmed:26944275
- pubmed:27002062
- pubmed:27146213
- pubmed:27192732
- pubmed:27217762
- pubmed:27221208
- pubmed:27236448
- pubmed:27252986
- pubmed:27265725
- pubmed:27274002
- pubmed:27335114
- pubmed:27346728
- pubmed:27389600
- pubmed:27403785
- pubmed:27450143
- pubmed:27503181
- reaxys:9629290
- wikipedia.en:Brivaracetam
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from brivaracetam
Phenotype where environments contain brivaracetam
Phenotype modified by environments containing brivaracetam
Phenotype affecting brivaracetam
Human Disease Model